MA46500B1 - Nouvelles combinaisons d'un antagoniste h3 et d'un inhibiteur de reuptake de noradrenaline, et leurs utilisations therapeutiques - Google Patents
Nouvelles combinaisons d'un antagoniste h3 et d'un inhibiteur de reuptake de noradrenaline, et leurs utilisations therapeutiquesInfo
- Publication number
- MA46500B1 MA46500B1 MA46500A MA46500A MA46500B1 MA 46500 B1 MA46500 B1 MA 46500B1 MA 46500 A MA46500 A MA 46500A MA 46500 A MA46500 A MA 46500A MA 46500 B1 MA46500 B1 MA 46500B1
- Authority
- MA
- Morocco
- Prior art keywords
- antagonist
- therapeutic uses
- reuptake inhibitor
- new combinations
- noradrenaline reuptake
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des combinaisons d'un antagoniste h3 et d'un antidépresseur, qui présentent une activité synergique favorisant le sillage.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18306017.7A EP3598975B1 (fr) | 2018-07-27 | 2018-07-27 | Nouvelles combinaisons d'un antagoniste h3 et un inhibiteur de la recapture de la noradrénaline et leurs utilisations thérapeutiques |
Publications (2)
Publication Number | Publication Date |
---|---|
MA46500A1 MA46500A1 (fr) | 2021-01-29 |
MA46500B1 true MA46500B1 (fr) | 2022-07-29 |
Family
ID=63144936
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA46500A MA46500B1 (fr) | 2018-07-27 | 2019-07-26 | Nouvelles combinaisons d'un antagoniste h3 et d'un inhibiteur de reuptake de noradrenaline, et leurs utilisations therapeutiques |
Country Status (18)
Country | Link |
---|---|
US (2) | US11229632B2 (fr) |
EP (1) | EP3598975B1 (fr) |
JP (1) | JP7509520B2 (fr) |
KR (1) | KR20200012781A (fr) |
CN (1) | CN110772515A (fr) |
BR (1) | BR102019015415A2 (fr) |
CA (1) | CA3050590A1 (fr) |
DK (1) | DK3598975T3 (fr) |
ES (1) | ES2840253T3 (fr) |
HU (1) | HUE052652T2 (fr) |
IL (1) | IL268208B (fr) |
MA (1) | MA46500B1 (fr) |
MX (1) | MX2019008637A (fr) |
PL (1) | PL3598975T3 (fr) |
PT (1) | PT3598975T (fr) |
TN (1) | TN2019000216A1 (fr) |
TW (2) | TW202007395A (fr) |
ZA (1) | ZA201904876B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3378858A1 (fr) * | 2017-03-21 | 2018-09-26 | Bioprojet | Tétrahydrate de ligand h3, son procédé de préparation et compositions pharmaceutiques le comprenant |
JP7234955B2 (ja) | 2020-01-31 | 2023-03-08 | トヨタ自動車株式会社 | 車両 |
WO2022159629A1 (fr) * | 2021-01-20 | 2022-07-28 | Alto Neuroscience, Inc. | Stratégie de combinaison de médicaments pour le traitement des troubles psychiatriques et neurologiques dans lesquels il existe une anhédonie ou un dysfonctionnement lié à la motivation |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1717235A3 (fr) | 2005-04-29 | 2007-02-28 | Bioprojet | Phenoxypropylpiperidines and -pyrrolidines et leur utilisation comme ligands du récepteur histaminique H3 |
EP3239138A1 (fr) * | 2016-04-25 | 2017-11-01 | Sandoz Ag | Sel de fumarate d'hydrogène de 1-[3-[3-(4-chlorophényl)propoxy]propyl]pipéridine |
-
2018
- 2018-07-27 HU HUE18306017A patent/HUE052652T2/hu unknown
- 2018-07-27 ES ES18306017T patent/ES2840253T3/es active Active
- 2018-07-27 PL PL18306017T patent/PL3598975T3/pl unknown
- 2018-07-27 EP EP18306017.7A patent/EP3598975B1/fr active Active
- 2018-07-27 PT PT183060177T patent/PT3598975T/pt unknown
- 2018-07-27 DK DK18306017.7T patent/DK3598975T3/da active
-
2019
- 2019-06-04 US US16/431,063 patent/US11229632B2/en active Active
- 2019-07-19 MX MX2019008637A patent/MX2019008637A/es unknown
- 2019-07-22 TN TNP/2019/000216A patent/TN2019000216A1/en unknown
- 2019-07-22 IL IL268208A patent/IL268208B/en unknown
- 2019-07-24 CA CA3050590A patent/CA3050590A1/fr active Pending
- 2019-07-25 KR KR1020190090305A patent/KR20200012781A/ko unknown
- 2019-07-25 TW TW108126312A patent/TW202007395A/zh unknown
- 2019-07-25 TW TW112133787A patent/TW202404587A/zh unknown
- 2019-07-25 ZA ZA2019/04876A patent/ZA201904876B/en unknown
- 2019-07-26 JP JP2019137983A patent/JP7509520B2/ja active Active
- 2019-07-26 CN CN201910681199.1A patent/CN110772515A/zh active Pending
- 2019-07-26 MA MA46500A patent/MA46500B1/fr unknown
- 2019-07-26 BR BR102019015415A patent/BR102019015415A2/pt unknown
-
2021
- 2021-11-26 US US17/456,617 patent/US20220079932A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
KR20200012781A (ko) | 2020-02-05 |
RU2019123563A (ru) | 2021-01-26 |
AU2019208166A1 (en) | 2020-02-13 |
MX2019008637A (es) | 2020-01-28 |
TN2019000216A1 (en) | 2021-01-07 |
MA46500A1 (fr) | 2021-01-29 |
IL268208B (en) | 2022-09-01 |
ES2840253T3 (es) | 2021-07-06 |
PL3598975T3 (pl) | 2021-04-19 |
HUE052652T2 (hu) | 2021-05-28 |
IL268208A (en) | 2019-11-28 |
JP2020015724A (ja) | 2020-01-30 |
BR102019015415A2 (pt) | 2020-01-28 |
US20220079932A1 (en) | 2022-03-17 |
EP3598975B1 (fr) | 2020-10-21 |
JP7509520B2 (ja) | 2024-07-02 |
DK3598975T3 (da) | 2020-11-02 |
US20200030310A1 (en) | 2020-01-30 |
ZA201904876B (en) | 2020-05-27 |
CA3050590A1 (fr) | 2020-01-27 |
TW202404587A (zh) | 2024-02-01 |
PT3598975T (pt) | 2020-12-21 |
CN110772515A (zh) | 2020-02-11 |
TW202007395A (zh) | 2020-02-16 |
EP3598975A1 (fr) | 2020-01-29 |
US11229632B2 (en) | 2022-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA46500B1 (fr) | Nouvelles combinaisons d'un antagoniste h3 et d'un inhibiteur de reuptake de noradrenaline, et leurs utilisations therapeutiques | |
BR112021024108A2 (pt) | Inibidores de tead e usos dos mesmos | |
BR112022011651A2 (pt) | Degradadores de irak e usos dos mesmos | |
EA202190377A9 (ru) | Композиции ингибиторов cxcr4 и способы получения и применения | |
CO2019009787A2 (es) | Anticuerpos contra triptasa, composiciones de estos y usos de estos | |
MA47736B1 (fr) | Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1 | |
CY1123871T1 (el) | Ανταγωνιστες ιντεγκρινης | |
EA201890322A1 (ru) | Новый вид тобамовируса | |
UY37560A (es) | Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta | |
EA201991863A1 (ru) | Составы амфетамина, препятствующие злоупотреблению | |
EA201992117A1 (ru) | Фармацевтическая комбинация, содержащая понесимод | |
AR120883A1 (es) | Anticuerpos anti-fgfr2b | |
MA54222A (fr) | Combinaison d'un inhibiteur de mcl-1 et de midostaurine, utilisations et compositions pharmaceutiques associées | |
EA201992352A1 (ru) | Фунгицидные комбинации | |
EA202192237A1 (ru) | Кристаллические формы ингибитора jak2 | |
AR120884A1 (es) | Anticuerpos anti-fgfr2b | |
CO2019007261A2 (es) | Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta | |
EA202190045A1 (ru) | Составы/композиции, содержащие ибрутиниб | |
MX2021004802A (es) | Una composicion antimicrobiana. | |
UA45476S (uk) | 1.-3. годинник наручний | |
TH19802C3 (th) | ผงปรุงรสแกงเห็ดกึ่งสำเร็จรูป | |
EA202190782A1 (ru) | Кормовая композиция для животных и ее применение | |
EA201991623A1 (ru) | Комбинация mcl-1 ингибитора и таксанового соединения, их применения и фармацевтические композиции | |
UA46550S (uk) | 1.-2. шампур | |
UA44859S (uk) | 1.-2. аромадифузор |